Ignite Creation Date:
2025-12-26 @ 10:58 AM
Ignite Modification Date:
2025-12-29 @ 2:31 PM
Study NCT ID:
NCT01458106
Status:
COMPLETED
Last Update Posted:
2020-12-19
First Post:
2011-10-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A
Sponsor:
Bioverativ Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11
Start Date Type:
None
Primary Completion Date:
2013-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-12
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-20
First Submit QC Date:
None
Study First Post Date:
2011-10-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-12-04
Results First Submit QC Date:
None
Results First Post Date:
2014-12-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-16
Last Update Post Date:
2020-12-19
Last Update Post Date Type:
ACTUAL